Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr. Lal PathLabs has informed that it attached transcript of Conference Call on Financial Results for Q1 FY24.
The above information is a part of company’s filings submitted to BSE.